-
Haemonetics (HAE) Acquires Vivasure Medical Limited, 'includes an upfront cash payment of €100 millio'
-
Needham Downgrades Haemonetics (HAE) to Hold, 'Interventional Tech Likely to Weigh on FY27 Growth'
-
BTIG Reiterates Buy Rating on Haemonetics (HAE)
-
Haemonetics (HAE) PT Raised to $90 at Raymond James
-
BofA Securities Upgrades Haemonetics (HAE) to Neutral
-
Haemonetics (HAE) PT Raised to $88 at BTIG
-
Haemonetics (HAE) PT Raised to $77 at Citi
-
Haemonetics (HAE) Tops Q2 EPS by 16c; offers guidance
-
Haemonetics (HAE) PT Lowered to $70 at Mizuho
-
Raymond James Downgrades Haemonetics (HAE) to Outperform, Removed from Analyst Current Favorite list
-
JPMorgan Downgrades Haemonetics (HAE) to Neutral
-
Haemonetics (HAE) PT Lowered to $68 at Needham
-
Haemonetics (HAE) Tops Q1 EPS by 9c
-
Baird Starts Haemonetics (HAE) at Outperform
-
Citi shuffles MedTech stocks: BDX downgraded, ITGR raised; reiterates top pick
-
Citizens JMP Reiterates Market Outperform Rating on Haemonetics (HAE)
-
Haemonetics (HAE) Tops Q4 EPS by 2c, provides guidance
-
BofA Comments on Trump and Mexico Tariff Delay Impact to Medical Technology Names
-
Haemonetics (HAE) Announces Executive Leadership Updates
-
Haemonetics (HAE) PT Lowered to $100 at JMP Securities
-
Haemonetics (HAE) PT Lowered to $105 at BTIG
-
Haemonetics (HAE) PT Lowered to $108 at Needham
-
Haemonetics (HAE) Tops Q3 EPS by 2c; updates guidance
-
Haemonetics (HAE) Completes Sale of Whole Blood Assets to GVS, S.p.A
-
Haemonetics (HAE) Announces Resignation of EVP of Global Manufacturing and Supply Chain Josep Llorens
-
JPMorgan Starts Haemonetics (HAE) at Overweight
-
BTIG Reiterates Buy Rating on Haemonetics (HAE)
-
Raymond James Upgrades Haemonetics (HAE) to Strong Buy
-
Needham Reiterates Buy Rating on Haemonetics (HAE)
-
Haemonetics (HAE) Tops Q2 EPS by 5c ; Offers Guidance
-
Aligos Therapeutics (ALGS) Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer
-
BofA Securities Starts Haemonetics (HAE) at Neutral
-
BTIG Starts Haemonetics (HAE) at Buy
-
Haemonetics (HAE) Announces Full Market Release for VASCADE MVP XL Vascular Closure System
-
Haemonetics (HAE) Tops Q1 EPS by 1c, provides guidance
-
Sotera Health Co. (SHC) Appoints Christopher Simon to its Board
-
Haemonetics (HAE) Announces CE Mark Certification for the SavvyWire Pre-Shaped Pressure Guidewire
-
Needham Upgrades Haemonetics (HAE) to Buy

